keyword
https://read.qxmd.com/read/38709984/implementing-a-clinical-pathway-for-needs-assessment-and-supportive-care-interventions
#1
JOURNAL ARTICLE
Nicole L Stout, Catherine M Alfano, Raymond Liu, Niharika Dixit, Michael Jefford
Despite advances in clinical cancer care, cancer survivors frequently report a range of persisting issues, unmet needs, and concerns that limit their ability to participate in life roles and reduce quality of life. Needs assessment is recognized as an important component of cancer care delivery, ideally beginning during active treatment to connect patients with supportive services that address these issues in a timely manner. Despite the recognized importance of this process, many health care systems have struggled to implement a feasible and sustainable needs assessment and management system...
May 6, 2024: JCO oncology practice
https://read.qxmd.com/read/38709980/geriatric-oncology-a-5-year-strategic-plan
#2
REVIEW
Fernando C Diaz, Anahid Hamparsumian, Kah Poh Loh, Haydeé Verduzco-Aguirre, Maya Abdallah, Grant R Williams, Tina Hsu, Enrique Soto-Perez-de-Celis, Rawad Elias
The increasing rate of the older adult population across the world over the next 20 years along with significant developments in the treatment of oncology will require a more granular understanding of the older adult population with cancer. The ASCO Geriatric Oncology Community of Practice (COP) herein provides an outline for the field along three fundamental pillars: education, research, and implementation, inspired by ASCO's 5-Year Strategic Plan. Fundamental to improving the understanding of geriatric oncology is research that intentionally includes older adults with clinically meaningful data supported by grants across all career stages...
June 2024: American Society of Clinical Oncology Educational Book
https://read.qxmd.com/read/38709933/a-high-fat-diet-promotes-cancer-progression-by-inducing-gut-microbiota-mediated-leucine-production-and-pmn-mdsc-differentiation
#3
JOURNAL ARTICLE
Jiewen Chen, Xiyuan Liu, Yi Zou, Junli Gong, Zhenhuang Ge, Xiaorong Lin, Wei Zhang, Hongyan Huang, Jianli Zhao, Phei Er Saw, Yongjun Lu, Hai Hu, Erwei Song
A high-fat diet (HFD) is a high-risk factor for the malignant progression of cancers through the disruption of the intestinal microbiota. However, the role of the HFD-related gut microbiota in cancer development remains unclear. This study found that obesity and obesity-related gut microbiota were associated with poor prognosis and advanced clinicopathological status in female patients with breast cancer. To investigate the impact of HFD-associated gut microbiota on cancer progression, we established various models, including HFD feeding, fecal microbiota transplantation, antibiotic feeding, and bacterial gavage, in tumor-bearing mice...
May 14, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38709925/cancer-stromal-cell-interactions-in-breast-cancer-brain-metastases-induce-glycocalyx-mediated-resistance-to-her2-targeting-therapies
#4
JOURNAL ARTICLE
Marie-Anne Goyette, Laura E Stevens, Carolyn R DePinho, Marco Seehawer, Jun Nishida, Zheqi Li, Callahan M Wilde, Rong Li, Xintao Qiu, Alanna L Pyke, Stephanie Zhao, Klothilda Lim, Gabrielle S Tender, Jason J Northey, Nicholas M Riley, Henry W Long, Carolyn R Bertozzi, Valerie M Weaver, Kornelia Polyak
Brain metastatic breast cancer is particularly lethal largely due to therapeutic resistance. Almost half of the patients with metastatic HER2-positive breast cancer develop brain metastases, representing a major clinical challenge. We previously described that cancer-associated fibroblasts are an important source of resistance in primary tumors. Here, we report that breast cancer brain metastasis stromal cell interactions in 3D cocultures induce therapeutic resistance to HER2-targeting agents, particularly to the small molecule inhibitor of HER2/EGFR neratinib...
May 14, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38709693/beyond-the-label-real-world-side-effects-experienced-with-fda-approved-drugs-for-non-melanoma-skin-cancers
#5
JOURNAL ARTICLE
Advaitaa Ravipati, Tejus Pradeep, Keyvan Nouri
With immunotherapy historically focused on cutaneous melanoma, there has been a new wave of systemic medications available for treating non-melanoma skin cancers including basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC). The immune checkpoint inhibitors approved by the FDA target programmed cell death protein 1 (PD-1) and the Hedgehog (Hh) signaling pathway. These medications have expanded treatment options; however, side effects are an important consideration. We used the FDA Adverse Events Reporting System (FAERS) to characterize the most prevalent, real-world side effects experienced by patients on these agents...
May 1, 2024: Journal of Drugs in Dermatology: JDD
https://read.qxmd.com/read/38709569/illusions-of-self-motion-during-magnetic-resonance-guided-focused-ultrasound-thalamotomy-for-tremor
#6
JOURNAL ARTICLE
Matteo Ciocca, Ayesha Jameel, Nada Yousif, Neekhil Patel, Joely Smith, Sena Akgun, Brynmor Jones, Wlayslaw Gedroyc, Dipankar Nandi, Yen Tai, Barry M Seemungal, Peter Bain
OBJECTIVE: Brain networks mediating vestibular perception of self-motion overlap with those mediating balance. A systematic mapping of vestibular perceptual pathways in the thalamus may reveal new brain modulation targets for improving balance in neurological conditions. METHODS: Here, we systematically report how magnetic resonance-guided focused ultrasound surgery of the nucleus ventralis intermedius of the thalamus commonly evokes transient patient-reported illusions of self-motion...
May 6, 2024: Annals of Neurology
https://read.qxmd.com/read/38709564/complement-terminal-pathway-activation-and-intrarenal-immune-response-in-c3-glomerulopathy
#7
JOURNAL ARTICLE
Marie-Sophie Meuleman, Florent Petitprez, Matthew C Pickering, Moglie Le Quintrec, Mikel Rezola Artero, Anna Duval, Marion Rabant, Alyssa Gilmore, Olivia Boyer, Julien Hogan, Aude Servais, François Provot, Vivianne Gnemmi, Maeva Eloudzeri, Anne Grunenwald, David Buob, Jean-Jacques Boffa, Anissa Moktefi, Vincent Audard, Jean-Michel Goujon, Frank Bridoux F, Eric Thervet, Alexandre Karras, Lubka T Roumenina, Véronique Frémeaux- Bacchi, Jean-Paul Duong Van Huyen, Sophie Chauvet
BACKGROUND: C3 glomerulopathy is a rare disease resulting from an overactivation of the complement alternative pathway. Although there is also evidence of terminal pathway activation, its occurrence and consequences on the disease have been poorly studied. METHODS: We retrospectively studied a cohort of 42 patients diagnosed with C3 glomerulopathy. We performed centralized extensive characterization of histological parameters. Kidney C5b-9 staining was performed as a marker of terminal pathway activation, intra-renal immune response was characterised through transcriptomic analysis...
May 6, 2024: Journal of the American Society of Nephrology: JASN
https://read.qxmd.com/read/38709478/imaging-cell-signaling-in-tissues-using-the-ibex-method
#8
JOURNAL ARTICLE
Yuxuan Meng, Changtai Li, Gregory S Patient, Yuan Tian, Colin J Chu
The study of cell signaling within tissues can be enhanced using highly multiplexed immunohistochemistry to localize the presence and spatial distribution of numerous pathways of interest simultaneously. Additional data can also be gained by placing the identified proteins into the context of adjacent structures, stroma, and interacting partners. Here, we outline a protocol for using the recently described IBEX method on tissues. This is an open and simple cyclic immunohistochemistry approach suited to this application...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38709435/roles-and-mechanisms-of-mirnas-in-abdominal-aortic-aneurysm-signaling-pathways-and-clinical-insights
#9
REVIEW
Haorui Zhang, Ke Zhang, Yuanrui Gu, Yanxia Tu, Chenxi Ouyang
PURPOSE OF REVIEW: Abdominal aortic aneurysm refers to a serious medical condition that can cause the irreversible expansion of the abdominal aorta, which can lead to ruptures that are associated with up to 80% mortality. Currently, surgical and interventional procedures are the only treatment options available for treating abdominal aortic aneurysm patients. In this review, we focus on the upstream and downstream molecules of the microRNA-related signaling pathways and discuss the roles, mechanisms, and targets of microRNAs in abdominal aortic aneurysm modulation to provide novel insights for precise and targeted drug therapy for the vast number of abdominal aortic aneurysm patients...
May 6, 2024: Current Atherosclerosis Reports
https://read.qxmd.com/read/38709422/past-present-and-future-therapeutic-strategies-for-nf-1-associated-tumors
#10
REVIEW
Brian Na, Shilp R Shah, Harish N Vasudevan
PURPOSE OF REVIEW: Neurofibromatosis type 1 (NF-1) is a cancer predisposition syndrome caused by mutations in the NF1 tumor suppressor gene that encodes the neurofibromin protein, which functions as a negative regulator of Ras signaling. We review the past, current, and future state of therapeutic strategies for tumors associated with NF-1. RECENT FINDINGS: Therapeutic efforts for NF-1-associated tumors have centered around inhibiting Ras output, leading to the clinical success of downstream MEK inhibition for plexiform neurofibromas and low-grade gliomas...
May 6, 2024: Current Oncology Reports
https://read.qxmd.com/read/38709420/kidney-failure-in-pauci-immune-crescentic-glomerulonephritis-rationale-for-immunosuppression-to-improve-kidney-outcome
#11
REVIEW
Faten Aqeel, Duvuru Geetha
PURPOSE OF REVIEW: Pauci-immune crescentic glomerulonephritis is the hallmark finding in ANCA-associated vasculitis (AAV) when the kidneys are affected. The rationale for immunosuppression in AAV is based on the underlying autoimmune nature of the disease. Overall remission rates, kidney outcomes, and the burden of disease have greatly improved since the discovery of various immunosuppressive therapies, but relapses remain common, and a significant proportion of patients continue to progress to end-stage kidney disease...
May 6, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38709345/endovascular-and-percutaneous-embolization-of-a-giant-post-traumatic-arteriovenous-fistula-of-inferior-epigastric-vessels
#12
JOURNAL ARTICLE
Venkata Subbaih Arunachalam, Smily Sharma, Jineesh Valakkada, Anoop Ayyappan, Jayakrishnan Radhakrishnan, Santhosh Kumar Kannath
BACKGROUND: Arteriovenous fistulas involving the anterior abdominal wall can result from trauma. Such fistulas may remain asymptomatic and undetected for a prolonged duration of time. They tend to recruit multiple arterial feeders with remodelling in the feeding arteries, making them challenging to treat. CASE PRESENTATION: We discuss a rare case of a 60-year-old male who presented with complaints of a progressive painless swelling in right lower abdomen. There was a history of blunt injury to abdomen at the same site during alleged road traffic accident 3 years ago...
May 6, 2024: CVIR Endovascular
https://read.qxmd.com/read/38709264/predictive-value-of-fcgbp-expression-for-treatment-response-and-survival-in-rectal-cancer-patients-undergoing-chemoradiotherapy
#13
JOURNAL ARTICLE
Yu-Ting Su, Chung-Hsing Chen, Jui-Wen Kang, Hsin-Yu Kuo, Ching-Chieh Yang, Yu-Feng Tian, Cheng-Fa Yeh, Chia-Lin Chou, Shang-Hung Chen
Despite neoadjuvant chemoradiotherapy (CRT) being the established standard for treating advanced rectal cancer, clinical outcomes remain suboptimal, necessitating the identification of predictive biomarkers for improved treatment decisions. Previous studies have hinted at the oncogenic properties of the Fc fragment of IgG binding protein (FCGBP) in various cancers; however, its clinical significance in rectal cancer remains unclear. In this study, we first conducted an analysis of a public transcriptome comprising 46 rectal cancer patients...
May 3, 2024: Aging
https://read.qxmd.com/read/38709261/double-ventricular-response-with-aberrant-conduction-leading-to-ventricular-dysfunction
#14
JOURNAL ARTICLE
Paul W Warren, Adam W Powell, Timothy Knilans, Chad Connor, Shankar Baskar
Double ventricular response (DVR), where a single P wave results in two QRS complexes, is a rare presentation of dual AV node physiology. It has been associated with ventricular dysfunction in the setting of incessant tachycardia. We present the case of an otherwise healthy adolescent who had frequent DVR without tachycardia leading to left ventricular dysfunction. Slow pathway modification led to a significant reduction in ectopy and normalization of ventricular function. This highlights that DVR without tachycardia might lead to ventricular dysfunction in pediatric patients...
May 6, 2024: Pediatric Cardiology
https://read.qxmd.com/read/38709242/transfected-sars-cov-2-spike-dna-for-mammalian-cell-expression-inhibits-p53-activation-of-p21-waf1-trail-death-receptor-dr5-and-mdm2-proteins-in-cancer-cells-and-increases-cancer-cell-viability-after-chemotherapy-exposure
#15
JOURNAL ARTICLE
Shengliang Zhang, Wafik S El-Deiry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes stabilization of tumor suppressor p53 protein. In-silico analysis previously suggested that SARS-CoV-2 spike interacts with p53 directly but this putative interaction has not been demonstrated in cells. We examined the interaction between SARS-CoV-2 spike, p53 and MDM2 (E3 ligase, which mediates p53 degradation) in cancer cells using an immunoprecipitation assay...
May 3, 2024: Oncotarget
https://read.qxmd.com/read/38709230/clinical-and-transcriptional-profiles-reveal-the-treatment-effect-of-adalimumab-in-patients-with-initial-onset-and-recurrent-vogt-koyanagi-harada-disease
#16
JOURNAL ARTICLE
Kailei Guo, Xuanrong Xu, Fuhua Yang, Kaixuan Wang, Xiaomin Zhang
PURPOSE: We aimed to evaluate adalimumab efficacy in patients with initial-onset or recurrent Vogt-Koyanagi-Harada (VKH) syndrome. METHODS: A retrospective clinical study was performed to examine the therapeutic effect of adalimumab in 22 VKH patients,16 with initial-onset and six with recurrent VKH. Another 22 patients with initial-onset VKH who did not receive adalimumab were included as controls. The main observational parameters included the central macular thickness (CMT), subfoveal choroidal thickness (SCT), best-corrected visual acuity (BCVA), anterior chamber cell grade (ACC), glucocorticoid dose (GCD), and the development of sunset glow fundus...
May 6, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38709221/provision-and-use-of-assistive-products-in-patients-after-stroke-and-spinal-cord-injury-in-germany-a-qualitative-interview-study
#17
JOURNAL ARTICLE
Tiziana Daniel, Tamara Spingler, Andreas Hug, Rüdiger Rupp, Norbert Weidner, Michel Wensing, Charlotte Ullrich
PURPOSE: Mobility impairments are a common consequence of stroke and spinal cord injury (SCI). Assistive products (APs) such as wheelchairs are often needed for activities and participation. The aim of the study was to explore the provision and use of APs in Germany and to identify associated factors underlying this practice. MATERIALS AND METHODS: Semi-structured interviews were conducted with 19 professionals from outpatient neurorehabilitation services (three general practitioners, five physical therapists, five occupational therapists, one speech therapist, one neuropsychologist, two outpatient nurses, one rehab technician and one social worker), two patient advocates (long-term survivors, each stroke and SCI) and 20 patients (10 each after stroke and SCI with mobility impairment, and first-ever affected)...
May 6, 2024: Disability and Rehabilitation. Assistive Technology
https://read.qxmd.com/read/38709120/understanding-the-mechanism-of-safety-attitude-mitigates-the-turnover-intention-novice-nurses-via-the-person-centred-method-a-theory-driven-deductive-cross-sectional-study
#18
JOURNAL ARTICLE
Xutong Zheng, Huan Liu, Man Zhang, Zhen Yang, Yong Dong, Zhuzhu Qin, Xiubin Tao, Xiancui Zhang, Aiping Wang
AIM: Examine profiles of safety attitudes among novices and explore whether profiles moderate the occupational identity-turnover pathway. BACKGROUND: Novice nurses face unique challenges in adopting positive safety attitudes, which influence outcomes like turnover. However, past research found only average levels of safety attitudes among novices, ignoring possible heterogeneity. Exploring whether meaningful subgroups exist based on safety perspectives and factors shaping them can provide insights to improve safety attitudes and retention...
May 6, 2024: Journal of Advanced Nursing
https://read.qxmd.com/read/38709075/pan-cancer-interrogation-of-b7-h3-cd276-as-an-actionable-therapeutic-target-across-human-malignancies
#19
JOURNAL ARTICLE
Carly D Miller, John R Lozada, Nicholas A Zorko, Andrew Elliott, Allison Makovec, Milan Radovich, Elisabeth I Heath, Neeraj Agarwal, Rana R McKay, Rohan Garje, Bruno R Bastos, Dave S Hoon, Jacob J Orme, Oliver Sartor, Ari Vanderwalde, Chadi Nabhan, George W Sledge, Eugene Shenderov, Scott M Dehm, Emil Lou, Jeffrey S Miller, Justin H Hwang, Emmanuel S Antonarakis
B7-H3 (CD276) is a transmembrane glycoprotein of the B7 immune checkpoint superfamily that has emerged as a promising therapeutic target. To better understand the applicability of B7-H3-directed therapies, we analyzed 156,791 samples comprising 50 cancer types to interrogate the clinical, genomic, transcriptomic, and immunological correlates of B7-H3 mRNA expression. DNA (592-gene/whole-exome) and RNA (whole-transcriptome) sequencing was performed from samples submitted to Caris Life Sciences (Phoenix, AZ)...
May 6, 2024: Cancer Res Commun
https://read.qxmd.com/read/38709052/exploring-metabolic-alterations-in-pycr2-deficiency-unveiling-pathways-and-clinical-presentations-of-hypomyelinating-leukodystrophy-10
#20
Berrak Bilginer Gürbüz, Basri Gülbakan, Rıza Köksal Özgül, Dilek Yalnızoğlu, Didem Yücel Yılmaz, Rahşan Göçmen, Can Koşukcu, Nurgün Kandemir, Neşe Vardar Acar, Bekir Salih, Ali Dursun
Proline-5-carboxylate reductase 2, encoded by PYCR2 gene, is an enzyme that catalyzes the last step of proline synthesis from pyrroline-5-carboxylate synthetase to proline. PYCR2 gene defect causes hypomyelinating leukodystrophy 10. Up until now, to our knowledge around 38 patients with PYCR2 defect have been reported. Herein, we describe clinical, neuroradiological, biochemical findings, and metabolomic profiling of three new genetically related cases of PYCR2 defects from a large family. Cerebrospinal fluid (CSF) amino acid levels were measured and untargeted metabolomic profiling of plasma and CSF were conducted and evaluated together with the clinical findings in the patients...
May 6, 2024: American Journal of Medical Genetics. Part A
keyword
keyword
162431
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.